News

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
Shares of GSK rose on Thursday after the company announced it had begun shipping its seasonal flu vaccines, Fluarix and ...
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...
Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...
Investing.com -- Sanofi (NASDAQ: SNY) has started shipping its flu vaccine portfolio for the 2025-2026 season to health facilities across the United States, the company announced today. The vaccine ...
As Ludhiana district continues to report new Covid-19 cases daily, concerns are mounting over the unavailability of vaccines.